Neurocrine Biosciences Raises FY23 INGREZZA Net Product Sales To $1.77B - $1.82B
Portfolio Pulse from Benzinga Newsdesk
Neurocrine Biosciences has increased its forecast for FY23 INGREZZA net product sales to $1.77 billion - $1.82 billion.
August 01, 2023 | 11:18 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Neurocrine Biosciences has raised its FY23 INGREZZA net product sales forecast, which could positively impact its stock price.
Neurocrine Biosciences has raised its FY23 INGREZZA net product sales forecast. This indicates a positive outlook for the company's revenue, which could lead to a positive impact on its stock price. Investors often react positively to increased revenue forecasts.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100